Newly Approved ALS Drug Priced At $158,000 Annually
Amylyx Pharmaceuticals revealed its recently FDA-approved Relyvrio drug would cost about $12,500 per 28-day prescription. The drugmaker noted it would give the drug free to certain uninsured patients. Separately, reports say the "Ice Bucket Challenge" actually helped fund Relyvrio's development.